Bank of America’s Windtree Therapeutics Inc WINT Stock Holding History
Bought
Maintained
Sold
Other funds holding WINT
Bank of America's WINT Position: Q2 2017 in Review
Bank of America sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 610 shares — an estimated $1K sold.
Bank of America first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $164K in Q2 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.
- Bank of America reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
- Bank of America sold 610 Windtree Therapeutics Inc shares in Q2 2017, an estimated $1K.
- Bank of America first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
- Bank of America's Windtree Therapeutics Inc position peaked at $164K in Q2 2013.
- 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.
Based on Bank of America's 13F filing for Q2 2017, filed 14 Aug 2017.